Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Kailera Therapeutics | Waltham | Series B | $600.0M | 2025-10-14 |
| Diagonal Therapeutics | Watertown | Series B | $125.0M | 2026-01-08 |
| Unbounce | Vancouver | Series A | $38.3M | 2020-06-17 |
| Comanche Biopharma | Concord | Series B | $75.0M | 2024-01-17 |
| Privy | Boston | Series A | $4.2M | 2018-10-25 |
| Trace Neuroscience | South San Francisco | Series A | $101.0M | 2024-11-12 |
| Aiolos Bio | San Francisco | Series A | $245.0M | 2023-10-24 |
| Nvelop Therapeutics | Cambridge | Seed | $100.0M | 2023-09-20 |
8 rows of the CSV in 5 of its 18 columns.
- The 47 Atlas Venture portfolio companies have raised $2.6B in total.
- 1 of them closed their most recent round in the last 12 months, $125.0M combined.
- The largest of those rounds is Diagonal Therapeutics' $125.0M Series B, dated January 2026.
- Techstars is an investor in 4 of them, more than any other fund.
- Software is the most common sector, with 34 companies (72%).
- 13% were founded in 2020 or later; the median founding year is 2010.
- The most common team size is 11 to 50 employees (52% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
14 of 47| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Diagonal Therapeutics | Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. | Biotech | Watertown, United States | Series B | $125.0M | 2026-01-08 | $253.0M | Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 | 11 to 50 | 2022 |
| Kailera Therapeutics | Kailera Therapeutics develops injectable and oral therapies for chronic weight management. | Biotech | Waltham, United States | Series B | $600.0M | 2025-10-14 | $1.0B | Atlas Venture, Bain Capital Life Sciences, RTW Investments | 101 to 250 | 2024 |
| Trace Neuroscience | Trace Neuroscience aims to extend the promise of genetic medicine to patients. | Biotech | South San Francisco, United States | Series A | $101.0M | 2024-11-12 | $101.0M | RA Capital Management, Atlas Venture, Third Rock Ventures | 11 to 50 | 2024 |
| Comanche Biopharma | Comanche Biopharma works to make pregnancies around the world safer. | Biotech | Concord, United States | Series B | $75.0M | 2024-01-17 | $111.1M | New Enterprise Associates, Google Ventures, F-Prime +2 | 11 to 50 | 2020 |
| Aiolos Bio | Aiolos Bio is a biotech company developing therapies for respiratory diseases and immune conditions. | Biotech | San Francisco, United States | Series A | $245.0M | 2023-10-24 | $245.0M | RA Capital Management, Atlas Venture, Forbion Capital Partners +2 | 11 to 50 | 2023 |
| Nvelop Therapeutics | Nvelop Therapeutics develops genetic medicines for patients with severe genetic diseases. | Biotech | Cambridge, United States | Seed | $100.0M | 2023-09-20 | $100.0M | F-Prime, Atlas Venture, 5AM Ventures +1 | 51 to 100 | 2022 |
| Unbounce | Unbounce provides a drag-and-drop builder for creating and publishing custom landing pages. | Software | Vancouver, Canada | Series A | $38.3M | 2020-06-17 | $39.1M | 500 Global, Real Ventures, Founders' Co-op +2 | 101 to 250 | 2009 |
| SimpleReach | SimpleReach is a content data platform that helps brands measure and improve content return on investment. | Artificial intelligence | New York, United States | Series B | $13.6M | 2017-04-21 | $24.2M | Wavemaker Ventures, Primary Venture Partners, Atlas Venture +2 | 51 to 100 | 2010 |
| Kinvey | Kinvey provides a backend-as-a-service that helps developers set up and run cloud backends for mobile apps. | Software | Boston, United States | Series B | $10.9M | 2014-09-23 | $17.9M | Techstars, Atlas Venture, NTT DOCOMO Ventures +2 | 11 to 50 | 2010 |
| CloudSwitch | CloudSwitch sells software that helps businesses run applications in the right cloud environment. | Software | Burlington, United States | Series B | $8.0M | 2009-06-29 | $15.4M | Matrix, Atlas Venture | 11 to 50 | 2008 |
| Liquid Machines | Liquid Machines develops enterprise rights management software that controls electronic corporate assets. | Hardware | Waltham, United States | Series D | $10.0M | 2008-02-04 | $27.1M | Goldman Sachs, RRE Ventures, Atlas Venture +1 | 11 to 50 | 2001 |
| Gotuit | Gotuit provides metadata technology that helps professional publishers get more value from stored video libraries. | Software | Woburn, United States | Series B | $10.0M | 2004-12-03 | $19.2M | Atlas Venture, Highland Capital Partners | 11 to 50 | 2000 |
| Livevault | Livevault provides online data backup and recovery services. | Software | San Antonio, United States | Series C | $5.0M | 2004-10-26 | $40.0M | Matrix, Dell Technologies Capital, Atlas Venture +1 | 51 to 100 | 1993 |
| Anadigm | Anadigm applies platform-based design to analog electronics using prequalified software and hardware components. | Hardware | Mesa, United States | Series C | $15.0M | 2003-10-02 | $34.6M | Atlas Venture, 3i Group, NIF Ventures +1 | 11 to 50 | 2000 |
Table 1. Atlas Venture portfolio companies: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 47.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Diagonal Therapeutics | Diagonal Therapeutics develops targeted therapies for cancer and genetic diseases. | Biotech | Watertown, United States | Series B | $125.0M | 2026-01-08 | $253.0M | Lightspeed Venture Partners, RA Capital Management, Atlas Venture +1 | 11 to 50 | 2022 |
Table 2. Atlas Venture portfolio companies: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Techstars | Startup accelerator | New York, United States | 4 | 9% | ||
| 2 | RA Capital Management | Startup incubator | Boston, United States | 3 | 6% | 1 | Diagonal Therapeutics |
| 3 | 500 Global | Startup accelerator | Palo Alto, United States | 3 | 6% | ||
| 4 | Matrix | Venture capital firm | Cambridge, United States | 3 | 6% | ||
| 5 | Accomplice | Family office | Cambridge, United States | 3 | 6% | ||
| 6 | Bain Capital Life Sciences | Private equity firm | Boston, United States | 2 | 4% | ||
| 7 | Real Ventures | Venture capital firm | Montréal, Canada | 2 | 4% | ||
| 8 | Google Ventures | Corporate venture arm | San Francisco, United States | 2 | 4% | ||
| 9 | F-Prime | Venture capital firm | Cambridge, United States | 2 | 4% | ||
| 10 | Polaris Partners | Private equity firm | Boston, United States | 2 | 4% | ||
| 11 | Alumni Ventures | Angel group | Manchester, United States | 2 | 4% | ||
| 12 | Hasso Plattner Ventures | Micro VC fund | Potsdam, Germany | 2 | 4% | ||
| 13 | Right Side Capital Management | Micro VC fund | San Francisco, United States | 2 | 4% | ||
| 14 | Sequoia Capital | Venture capital firm | Menlo Park, United States | 2 | 4% | ||
| 15 | RTW Investments | Hedge fund | New York, United States | 1 | 2% |
Table 3. Atlas Venture portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 34 | 72% | $580.5M |
| Health care | 9 | 19% | $1.9B |
| Biotech | 7 | 15% | $1.8B |
| Commerce | 7 | 15% | $184.3M |
| Hardware | 6 | 13% | $120.4M |
| Cybersecurity | 5 | 11% | $126.1M |
| Fintech | 5 | 11% | $104.3M |
| Artificial intelligence | 2 | 4% | $76.1M |
| Education | 1 | 2% | $8.2M |
Table 4. Atlas Venture portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Atlas Venture portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United States | 37 | 79% |
| Canada | 2 | 4% |
| Germany | 2 | 4% |
| France | 2 | 4% |
| United Kingdom | 2 | 4% |
| Spain | 1 | 2% |
| Switzerland | 1 | 2% |
Table 6. Atlas Venture portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Boston | 8 | 17% |
| San Francisco | 6 | 13% |
| Cambridge | 5 | 11% |
| New York | 4 | 9% |
| Waltham | 2 | 4% |
| Redwood City | 2 | 4% |
| Bristol | 2 | 4% |
| Watertown | 1 | 2% |
| Vancouver | 1 | 2% |
| Concord | 1 | 2% |
| South San Francisco | 1 | 2% |
| Oakland | 1 | 2% |
Table 7. Atlas Venture portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| January 2026 | 1 | 100% | $125.0M |
Table 8. Atlas Venture portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 1 | 2% | $125.0M |
| 2025 | 1 | 2% | $600.0M |
| 2024 | 2 | 4% | $176.0M |
| 2023 | 2 | 4% | $345.0M |
| 2020 | 2 | 4% | $88.3M |
| 2019 | 1 | 2% | $14.0M |
Table 9. Atlas Venture portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 6% |
| 2020 to 2022 | 3 | 6% |
| 2010 to 2014 | 18 | 38% |
| Before 2010 | 23 | 49% |
Table 10. Atlas Venture portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 2 | 4% |
| 11 to 50 | 24 | 52% |
| 51 to 100 | 14 | 30% |
| 101 to 250 | 4 | 9% |
| 5,001 to 10,000 | 2 | 4% |
Table 11. Atlas Venture portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Atlas Venture is recorded as one of its investors. On 16 November 2026 that is 47 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 14 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 47 rows: 1 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Atlas Venture portfolio companies are on the list?
- 47, in the file dated 16 November 2026. 1 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 47 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.